(Q35084775)

6 August 2017

1 reference

title

The clinical evaluation of HER-2 status: which test to use? (English)

1 reference

6 August 2017

John Bartlett

1

1 reference

PubMed ID

12635130

6 August 2017

Elizabeth Mallon

series ordinal

2

1 reference

PubMed ID

12635130

6 August 2017

Tim Cooke

series ordinal

3

1 reference

6 August 2017

1 April 2003

1 reference

6 August 2017

1 reference

6 August 2017

199

1 reference

6 August 2017

411-417

1 reference

6 August 2017

4

1 reference

Oncogene amplification and expression. Importance of methodologic considerations

6 August 2017

1 reference

Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

21 January 2018

1 reference

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

Quantitative radioimmunohistochemical measurements of p185(erbB-2) in frozen tissue sections

21 January 2018

1 reference

Localization of EGF receptors in frozen tissue sections by antibody and biotinylated EGF-based techniques

21 January 2018

1 reference

Chromosomal aberrations in transitional cell carcinoma that are predictive of disease outcome are independent of polyploidy

21 January 2018

1 reference

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.1354

1 reference

6 August 2017

1 reference

PubMed ID

12635130